Vistim Labs is a MedTech company developing accessible neurodiagnostic solutions for neurodegenerative diseases. Their flagship platform, Ceregram, uses EEG-based visual processing and AI to help clinicians objectively monitor brain function in Alzheimer’s, dementia, Parkinson’s, and related conditions.
Designed for routine clinical use, Ceregram enables fast, non-invasive assessments directly in neurology practices and memory clinics.
What Makes It Different
Unlike traditional cognitive testing or expensive imaging workflows, Ceregram delivers real-time physiological insights into how the brain processes information.
The platform supports:
- Early detection of cognitive decline
- Therapy response monitoring
- Longitudinal disease tracking
- Personalized treatment decisions
Current Status
Ceregram is commercially available in private neurology practices across the United States and continues to expand through clinical partnerships and validation studies.
NMV Collaboration
Neuromotion Ventures supports Vistim Labs with strategic neurotechnology expertise, commercialization guidance, and access to deep scientific and hardware development networks.